You are here

Article info

Article menu
Download PDFPDF
Paper
Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension

Authors

  • T Higenbottam aSection of Respiratory Medicine, Division of Clinical Sciences, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK, bDepartment of Respiratory Physiology, Papworth Hospital, Cambridge, UK, cDepartment of Research and Development, Papworth Hospital, Cambridge, and MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK PubMed articlesGoogle scholar articles
  • A Y Butt aSection of Respiratory Medicine, Division of Clinical Sciences, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK, bDepartment of Respiratory Physiology, Papworth Hospital, Cambridge, UK, cDepartment of Research and Development, Papworth Hospital, Cambridge, and MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK PubMed articlesGoogle scholar articles
  • A McMahon aSection of Respiratory Medicine, Division of Clinical Sciences, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK, bDepartment of Respiratory Physiology, Papworth Hospital, Cambridge, UK, cDepartment of Research and Development, Papworth Hospital, Cambridge, and MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK PubMed articlesGoogle scholar articles
  • R Westerbeck aSection of Respiratory Medicine, Division of Clinical Sciences, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK, bDepartment of Respiratory Physiology, Papworth Hospital, Cambridge, UK, cDepartment of Research and Development, Papworth Hospital, Cambridge, and MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK PubMed articlesGoogle scholar articles
  • L Sharples aSection of Respiratory Medicine, Division of Clinical Sciences, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK, bDepartment of Respiratory Physiology, Papworth Hospital, Cambridge, UK, cDepartment of Research and Development, Papworth Hospital, Cambridge, and MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK PubMed articlesGoogle scholar articles
  1. Professor T Higenbottam, Division of Clinical Sciences, Section of Respiratory Medicine, Floor F, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK.
View Full Text

Citation

Higenbottam T, Butt AY, McMahon A, et al
Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension
Heart 1998;80:151-155.

Publication history

  • Accepted April 24, 1998
  • First published August 1, 1998.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

British Cardiac Society